摘要
目的探讨麻醉下内镜介入治疗胆道疾病的实施方法、管理以及安全性。方法25例择期行内镜介入治疗胆道疾病病人,口服局麻药5～10min后,静脉输注丙泊酚0.5mg/kg,氯胺酮0.3mg/kg,入睡后行内镜介入治疗。结果血压、心率、呼吸、血氧饱和度,与治疗前比较差异无显著性。治疗过程中无痛苦、无知晓,操作安静、松弛、快速。术中无记忆,术后无燥动与不安。结论应用亚剂量丙泊酚与氯胺酮可安全实施内镜介入治疗胆道疾病病人。
[Objective] To study the management and safety of anesthesia in therapy of biliary tract disease by endoscopic. [Methords] 25 elective-patients with biliary tract diseases, after local anesthetic po 5-10 min, propofol 0.5 mg/kg and ketamine 0.3 mg/kg iv. [Results] No significant difference of blood pressure, heart rate, breath and SpO2 comparating with pre-operation. There was no pain or perception and patients were silent relaxant in the course of operation, no restlessness post-operation. [Conclusion] It is safe with sub-nose propofol and ketamine to the biliary tract disease patients by endoscopic.
出处
《中国内镜杂志》
CSCD
北大核心
2005年第10期1062-1063,共2页
China Journal of Endoscopy
关键词
丙泊酚
氯胺酮
内镜
胆道疾病
propofol
ketamine
endoscopic
biliary tract diseases
